Suggestive evidence that the highly metastatic variant ESB of the T‐cell lymphoma eb is derived from spontaneous fusion with a host macrophage
- 1 November 1984
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 34 (5), 699-707
- https://doi.org/10.1002/ijc.2910340518
Abstract
Two lines of evidence are reported which suggest that the highly metastatic variant ESb of the T‐cell lymphoma Eb is derived from spontaneous fusion with a host macrophage. Firstly, ESb cells are shown to express the macrophage differentiation antigen Mac‐1 which was not found on Eb cells or on any other tumor cells tested except the macrophage tumor line Pu5. Secondly, the progression from low to high metastatic capacity could be reproduced in vitrofollowing hybridization of thioguanine‐resistant Eb cells (EbTGR) with syngeneic bone‐marrow‐derived macrophages. Two HAT medium‐selected hybrid tumor lines (Eb‐F1 and Eb‐F2) could be established. They were found to express cell surface markers of both parental lines: T lymphoid differentiation antigens from T‐lymphoma and macrophage antigens (Mac‐1, class II MHC antigens) from the normal cell fusion partner. The antigens were identified on the hybrids and subclones thereof by means of monoclonal antibodies and 3 different detection assays: cytofluorography, complement‐dependent cytotoxocity and immunoprecipitation followed by gel electrophoresis. Animals inoculated s.c. with the parental line EbTGR developed local tumors but not metastases and survived for more than 40 days. In contrast, animals inoculated similarly with Eb‐F1 or Eb‐F2 cells quickly developed metastases in visceral organs and died as early as 10‐14 days following inoculation. In many but not all respects, the in vitro‐derived Tlymphoma‐macrophage hybrids resembled the spontaneous in vivo‐derived variant ESb. These findings, together with the presence of Mac‐1 antigen on ESb cells, suggest (1) that ESb variant cells may be derived from spontaneous fusion with a host cell, most likely a macrophage and (2) that somatic cell fusion may be an important mechanism of genetic rearrangements leading to metastatic variants. The new highly metastatic tumor lines which were developed under well‐defined in vitro conditions, and their subclones, may become very useful tools for studying the contribution of specific genetic traits and of membranerelated structures to various steps of the metastatic process.Keywords
This publication has 35 references indexed in Scilit:
- New plasma membrane proteins expressed by a high metastatic variant of a chemically induced tumorEuropean Journal of Cancer and Clinical Oncology, 1984
- Glycoconjugates of murine tumor lines with different metastatic capacities. I. Differences in fucose utilization and in glycoprotein patternsInternational Journal of Cancer, 1984
- High-grade tumor-specific immunity induced by L1210 leukemia variants obtained from the culture of L1210 cells fused with Lesch-Nyhan fibroblastsInternational Journal of Cancer, 1983
- Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation.The Journal of Experimental Medicine, 1983
- Cytogenetic changes during tumor progression towards invasion, metastasis and immune escape in the Eb/ESb model systemInternational Journal of Cancer, 1982
- Cross‐blocking studies with monoclonal antibodies against I‐A molecules of haplotypes b, d and kEuropean Journal of Immunology, 1982
- Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variantEuropean Journal of Immunology, 1982
- Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice. VIII. Expression and shedding of Fcγ receptors on metastatic tumor cell variantsJournal of Supramolecular Structure, 1979
- Premature chromosome condensation in carcinoma of the bladder: presumptive evidence for fusion of normal and malignant cellsCytogenetic and Genome Research, 1979
- In vivo Hybridisation of Cultured Melanoma Cells and Isogenic Normal Mouse CellsDifferentiation, 1975